Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
- Status
- COMPLETED
- Phase
- PHASE1
Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada
- Status
- COMPLETED
- Phase
- N/A
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Denosumab Safety Assessment in Multiple Observational Databases
- Status
- COMPLETED
- Phase
- N/A
MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)
- Status
- UNKNOWN
- Phase
- N/A
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
- Status
- TERMINATED
- Phase
- PHASE2
Complement Inhibition in aHUS Dialysis Patients
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
- Status
- COMPLETED
- Phase
- PHASE3
TVEC and Preop Radiation for Sarcoma (4 ml Dose)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1